![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, September 03, 2014 8:17:33 PM
My dd from the opinions of textile execs outside of KBLB & WM have not led me astray so far and have in fact reinforced my opinion of where KBLB/WM stands with MS tonnage and commercialization. Kim T. set up conservative mid-year expectations of MS tonnage. Granted Kim is 45- 75 days past an expectation that he set up many months ago (depending on how one defines mid-year). Disruptive biotech doesn't progress on a linear plane or timeline. I've paid more attention to what Charlie Howland has commented on in the last several joint PR's as to MS weaving progress.
REPOST:
As to tonnage, I'm of the opinion that KBLB has already produced tonnage of MS at the filature. The question not addressed on this MB is consistency/quality/specified use for proof of concept for a specified customer to the satisfaction of that specified customer. I've been told by fiber execs from other companies that even the lesser quality MS will have a high degree of marketability, just not for the IED protective clothing DOD market. Homozeigosity of MS thread was achieved several years ago. KT being historically conservative in his PR's, will only announce tonnage when the MS yarn tonnage reaches the level of high quality, consistent MS yarn woven by WM to clinch "proof of concept" for a specific use and specified customer of MS. KT has set up these expectations and timelines in his earlier PR's for a mid-year rollout. At this point he's late meeting his own earlier projections. So be the nature of disruptive tech. The next PR could include details of a specific MS customer and use thru WM - IMO. It could be a blockbuster PR. I won't speculate when it's coming.
Best regards - yankee
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM